Fig. 1. The chemical structures of the substrate (1) and product (2) of the rate limiting step of the kynurenine pathway are shown in the dashed box. The chemical structures of drug candidates targeting IDO1 (3–6) are shown outside of the box. The structures of compounds 5 and 6 are undisclosed.